Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

 

Crushed it: Elucidation of systemic vasculitis caused by injected hydromorphone tablets via skin biopsy

Describes a case of medical complications from injected hydromorphone tablets
Case study | 2019
About prescribers, Injecting drugs

Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic

We discuss how COVID-19 has ended the practice of “routine” UDT in office-based opioid treatment (OBOT), encouraged a more patient-centered approach, and why targeted, as opposed to routine, UDT shoul
Commentary | 2020
Evidence base, Policy/Regulatory, About prescribers

Increasing diversion of methadone in Vancouver, Canada, 2005–2015

Recent studies have found that methadone was identified in more than a quarter of prescription opioid-related deaths among people who use illicit drugs in Vancouver, Canada.
Original research | 2018
Evidence base, Harm reduction, Safer supply, About prescribers, Substitution/OAT, Diversion

Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users

Examine the specific practice of injecting someone else's drug residue as a possible route of HCV transmission.
Original research | 2012
Evidence base, Safer supply, Illegal drugs, Youth

Legalization of recreational cannabis: Facilitators and barriers to switching from an illegal to a legal source

This study aimed to identify perceived facilitators/barriers of switching from an illicit to a licit cannabis source.
Original research | 2021
Policy/Regulatory, Decriminalization/legalization, Barriers and enablers, Stigma

Measures to support a safer drug supply

Commentary on Tyndall
Letter | 2020
Policy/Regulatory, Hesitancy of prescribers , Safer supply, Decriminalization/legalization, Equity, Advocacy, About prescribers, Barriers and enablers

Opioid overdose deaths and the expansion of opioid agonist treatment: A population-based prospective cohort study

To estimate the causal effects of a national opioid agonist treatment (OAT) program on population level drug fatalities.
Original research | 2021
Overdose, Mortality, Evidence base, Harm reduction, Policy/Regulatory, Hesitancy of prescribers , Safer supply, Advocacy, About prescribers, Outcomes, Substitution/OAT

Opioid- and Stimulant-related Harms in Canada

Webpage | 2021
Overdose, Mortality, Social services, Outcomes, Illegal drugs, Sex/Gender , Hospitals

Patient, medical and legal perspectives on reentry: the need for a low-barrier, collaborative, patient-centered approach

To inform an intervention aimed at helping recently-released people with HIV and SUD, we conducted a qualitative study to assess barriers and facilitators to community reentry from the perspectives of
Original research | 2021
Harm reduction, Wrap-around services, About PWUD, Social services, Legal system/law enforcement, Illegal drugs

Persons from racial and ethnic minority groups receiving medication for opioid use disorder experienced increased difficulty accessing harm reduction services during COVID-19

We tested the hypothesis that persons receiving medication for opioid use disorder (MOUD) who self-identify as from racial/ethnic minority groups would experience more disruptions in access to harm re
Original research | 2021
Equity, About PWUD

Privileged background protects against drug charges: A long-term population-based longitudinal study

We investigated the importance of indicators of parental socio-economic status (SES) for getting an official drug charge, while we controlled for self-reported drug law infractions (use of illegal dru
Original research | 2022
Equity, Illegal drugs

Reducing Drug Users' Risk of Overdose

Research project looking at ways of reducing drug users’ risk of overdose, conducted on behalf of the Scottish Government.
Report | 2008
Overdose, Harm reduction, About pharmacists, About prescribers, Social services, Legal system/law enforcement

Research led by people who use drugs: centering the expertise of lived experience

PWUD play a critical role in identifying emerging issues in the drug market, as well as associated health behaviors and outcomes.
Commentary | 2021
About PWUD, Peer/PWLLE program involvement

Risk factors associated with drug use: the importance of ‘risk environment’

This paper discusses research findings on non-biological risk factors associated with illicit drug use
Original research | 2003
Harm reduction, Illegal drugs

The opioid crisis is driving mortality among under-served people living with HIV in British Columbia, Canada

To illuminate persistent threats to the health and longevity of under-served PLWH in BC
Original research | 2021
Overdose, Mortality, Equity, Outcomes, Poverty, Sex/Gender

Using TikTok in recovery from substance use disorder

Given the rising popularity of TikTok and need to foster innovative means through which to attract and engage individuals with SUD with treatment, we sought to characterize how TikTok users in SUD rec
Original research | 2021
About PWUD, Illegal drugs, Transitions in care/treatment, Digital health

Wearable biosensors have the potential to monitor physiological changes associated with opioid overdose among people who use drugs: A proof-of-concept study in a real-world setting

Wearable biosensors have the potential to monitor physiological change associated with opioid overdose among people who use drugs.
Original research | 2021
Harm reduction, About PWUD, Illegal drugs, Digital health

‘Small communities, large oversight’: The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada

Commentary | 2020
Policy/Regulatory, Equity, Advocacy, Small/medium cities, SCS/OPS

2019 Opioid Mortality in Ontario and preliminary 2020 trends

Slide deck | 2020
Mortality, Evidence base, Advocacy, Illegal drugs, Indigenous, Stimulants, Sex/Gender

5 Things You Should Know About Safer Opioid Supply Programs

Commentary | 2021
Clinical guidance, Harm reduction, Hesitancy of prescribers , Safer supply, About pharmacists

Refine Your Search

Keywords
Format
Region